United Therapeutics Corporation Increase (Decrease) in Accounts Payable and Accrued Liabilities
United Therapeutics Corporation (UTHR) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$16.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-05
- United Therapeutics Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$4.00M, a 108.68% decline year-over-year.
- United Therapeutics Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$12.70M.
- United Therapeutics Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $23.20M.
- United Therapeutics Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $31.20M, a 5.45% decline year-over-year.
- United Therapeutics Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $97.90M, a 129.27% increase from fiscal 2024.
- United Therapeutics Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $42.70M, a 25.22% decline from fiscal 2023.
- United Therapeutics Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $57.10M, a 28.31% increase from fiscal 2022.
- United Therapeutics Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $44.50M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$16.70M 10-Q · filed 2026-08-05 | $6.50M derived: sum of 3 quarters · filed 2026-08-05 | $37.70M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$12.70M 10-Q · filed 2026-05-06 | $10.50M derived: sum of 2 quarters · filed 2026-05-06 | $41.70M derived: sum of 3 quarters · filed 2026-05-06 | $87.80M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $23.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $54.40M derived: sum of 2 quarters · filed 2026-02-25 | $100.50M derived: sum of 3 quarters · filed 2026-08-05 | $97.90M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $31.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $77.30M derived: sum of 2 quarters · filed 2026-08-05 | $74.70M 10-Q · filed 2025-10-29 | $56.70M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $46.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $43.50M 10-Q · filed 2026-08-05 | $25.50M derived: sum of 3 quarters · filed 2026-08-05 | $58.50M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$2.60M 10-Q · filed 2026-05-06 | -$20.60M derived: sum of 2 quarters · filed 2026-05-06 | $12.40M derived: sum of 3 quarters · filed 2026-05-06 | $38.20M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $15.00M derived: sum of 2 quarters · filed 2026-02-25 | $40.80M derived: sum of 3 quarters · filed 2026-02-25 | $42.70M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $33.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $58.80M derived: sum of 2 quarters · filed 2025-10-29 | $60.70M 10-Q · filed 2025-10-29 | $37.60M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $25.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $27.70M 10-Q · filed 2025-07-30 | $4.60M derived: sum of 3 quarters · filed 2026-02-25 | $44.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $1.90M 10-Q · filed 2025-04-30 | -$21.20M derived: sum of 2 quarters · filed 2026-02-25 | $18.20M derived: sum of 3 quarters · filed 2026-02-25 | $56.20M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | -$23.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $16.30M derived: sum of 2 quarters · filed 2026-02-25 | $54.30M derived: sum of 3 quarters · filed 2026-02-25 | $57.10M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $39.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $77.40M derived: sum of 2 quarters · filed 2024-10-30 | $80.20M 10-Q · filed 2024-10-30 | $89.30M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $38.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $40.80M 10-Q · filed 2024-07-31 | $49.90M derived: sum of 3 quarters · filed 2025-02-26 | $72.20M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $2.80M 10-Q · filed 2024-05-01 | $11.90M derived: sum of 2 quarters · filed 2025-02-26 | $34.20M derived: sum of 3 quarters · filed 2025-02-26 | $58.10M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $31.40M derived: sum of 2 quarters · filed 2025-02-26 | $55.30M derived: sum of 3 quarters · filed 2025-02-26 | $44.50M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $22.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $46.20M derived: sum of 2 quarters · filed 2023-11-01 | $35.40M 10-Q · filed 2023-11-01 | $900.00K derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | $23.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $13.10M 10-Q · filed 2023-08-02 | -$21.40M derived: sum of 3 quarters · filed 2024-02-21 | -$1.60M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | -$10.80M 10-Q · filed 2023-05-03 | -$45.30M derived: sum of 2 quarters · filed 2024-02-21 | -$25.50M derived: sum of 3 quarters · filed 2024-02-21 | $1.70M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | -$34.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$14.70M derived: sum of 2 quarters · filed 2024-02-21 | $12.50M derived: sum of 3 quarters · filed 2024-02-21 | -$12.50M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | $19.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $47.00M derived: sum of 2 quarters · filed 2022-11-02 | $22.00M 10-Q · filed 2022-11-02 | $32.70M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $27.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $2.20M 10-Q · filed 2022-08-03 | $12.90M derived: sum of 3 quarters · filed 2023-02-22 | $38.20M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | -$25.00M 10-Q · filed 2022-05-04 | -$14.30M derived: sum of 2 quarters · filed 2023-02-22 | $11.00M derived: sum of 3 quarters · filed 2023-02-22 | $32.40M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $10.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $36.00M derived: sum of 2 quarters · filed 2023-02-22 | $57.40M derived: sum of 3 quarters · filed 2023-02-22 | $38.60M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $25.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $46.70M derived: sum of 2 quarters · filed 2021-11-03 | $27.90M 10-Q · filed 2021-11-03 | $16.50M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $21.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $2.60M 10-Q · filed 2021-08-04 | -$8.80M derived: sum of 3 quarters · filed 2022-02-24 | -$10.70M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | -$18.80M 10-Q · filed 2021-05-05 | -$30.20M derived: sum of 2 quarters · filed 2022-02-24 | -$32.10M derived: sum of 3 quarters · filed 2022-02-24 | -$7.40M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$11.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$13.30M derived: sum of 2 quarters · filed 2022-02-24 | $11.40M derived: sum of 3 quarters · filed 2022-02-24 | -$16.30M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $22.80M derived: sum of 2 quarters · filed 2020-10-28 | -$4.90M 10-Q · filed 2020-10-28 | -$37.80M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $24.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$3.00M 10-Q · filed 2020-07-29 | -$35.90M derived: sum of 3 quarters · filed 2021-02-24 | -$53.90M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | -$27.70M 10-Q · filed 2020-04-29 | -$60.60M derived: sum of 2 quarters · filed 2021-02-24 | -$78.60M derived: sum of 3 quarters · filed 2021-02-24 | -$60.70M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | -$32.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$50.90M derived: sum of 2 quarters · filed 2021-02-24 | -$33.00M derived: sum of 3 quarters · filed 2021-02-24 | -$11.00M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | -$18.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$100.00K derived: sum of 2 quarters · filed 2019-10-30 | $21.90M 10-Q · filed 2019-10-30 | $50.20M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $17.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $39.90M 10-Q · filed 2019-07-31 | $68.20M derived: sum of 3 quarters · filed 2020-02-26 | $85.30M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $22.00M 10-Q · filed 2019-05-01 | $50.30M derived: sum of 2 quarters · filed 2020-02-26 | $67.40M derived: sum of 3 quarters · filed 2020-02-26 | $89.30M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $28.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $45.40M derived: sum of 2 quarters · filed 2020-02-26 | $67.30M derived: sum of 3 quarters · filed 2020-02-26 | $66.20M 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | $17.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $39.00M derived: sum of 2 quarters · filed 2018-10-31 | $37.90M 10-Q · filed 2018-10-31 | $24.60M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $21.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $20.80M 10-Q · filed 2018-08-01 | $7.50M derived: sum of 3 quarters · filed 2019-02-27 | $1.60M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | -$1.10M 10-Q · filed 2018-05-02 | -$14.40M derived: sum of 2 quarters · filed 2019-02-27 | -$20.30M derived: sum of 3 quarters · filed 2019-02-27 | -$1.00M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | -$13.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$19.20M derived: sum of 2 quarters · filed 2019-02-27 | $100.00K derived: sum of 3 quarters · filed 2019-02-27 | $600.00K 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | -$5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | $13.40M derived: sum of 2 quarters · filed 2017-10-25 | $13.90M 10-Q · filed 2017-10-25 | $5.10M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-06-30 | $19.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $19.80M 10-Q · filed 2017-07-27 | $11.00M derived: sum of 3 quarters · filed 2018-02-21 | $13.50M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-03-31 | $500.00K 10-Q · filed 2017-04-26 | -$8.30M derived: sum of 2 quarters · filed 2018-02-21 | -$5.80M derived: sum of 3 quarters · filed 2018-02-21 | $12.80M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2015-12-31 | -$8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$6.30M derived: sum of 2 quarters · filed 2018-02-21 | $12.30M derived: sum of 3 quarters · filed 2018-02-21 | $17.00M 10-K · filed 2018-02-21 | $16.97M 10-K · filed 2016-02-25 | |||
| 2015-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $21.10M derived: sum of 2 quarters · filed 2016-10-27 | $25.80M 10-Q · filed 2016-10-27 | $25.82M 10-Q · filed 2015-10-27 | -$16.86M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-06-30 | $18.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $23.30M 10-Q · filed 2016-07-28 | $23.33M 10-Q · filed 2015-07-28 | -$19.36M derived: sum of 3 quarters · filed 2017-02-22 | -$3.52M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-03-31 | $4.70M 10-Q · filed 2016-04-28 | $4.75M 10-Q · filed 2015-04-28 | -$37.95M derived: sum of 2 quarters · filed 2017-02-22 | -$22.12M derived: sum of 3 quarters · filed 2017-02-22 | -$13.82M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2014-12-31 | -$42.66M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | -$26.82M derived: sum of 2 quarters · filed 2017-02-22 | -$18.52M derived: sum of 3 quarters · filed 2017-02-22 | -$6.80M 10-K · filed 2017-02-22 | -$6.75M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | $15.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $24.13M derived: sum of 2 quarters · filed 2015-10-27 | $35.85M 10-Q · filed 2015-10-27 | $30.73M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | $8.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28 | $20.02M 10-Q · filed 2015-07-28 | $14.89M derived: sum of 3 quarters · filed 2016-02-25 | $20.76M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | $11.72M 10-Q · filed 2015-04-28 | $6.60M derived: sum of 2 quarters · filed 2016-02-25 | $12.47M derived: sum of 3 quarters · filed 2016-02-25 | $23.15M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | -$5.13M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $744.00K derived: sum of 2 quarters · filed 2016-02-25 | $11.42M derived: sum of 3 quarters · filed 2016-02-25 | $7.51M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | $5.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $16.55M derived: sum of 2 quarters · filed 2014-10-28 | $12.63M 10-Q · filed 2014-10-28 | -$3.05M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $10.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29 | $6.76M 10-Q · filed 2014-07-29 | -$8.92M derived: sum of 3 quarters · filed 2015-02-24 | |||||
| 2013-03-31 | -$3.92M 10-Q · filed 2014-04-29 | -$19.60M derived: sum of 2 quarters · filed 2015-02-24 | ||||||
| 2012-12-31 | -$15.68M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$22.80M 10-K · filed 2015-02-24 | ||||||
| 2012-09-30 | -$7.12M 10-Q · filed 2013-10-29 | |||||||
| 2011-12-31 | $20.25M 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |